IA para medicina nuclear: Detección automática de anormalidades en exámenes PET-CT FDG

CódigoEEN TRFR20240829013
Alta en la Red: 3/9/2024
Deadline: 29/8/2025
Tipo: Demanda

Descripción A French software company has developed a medical device for PET-CT examination with FDG. This medical device detects, segments and quantifies abnormalities on PET-CT FDG examinations. It brings biomarkers directly into clinical routine and helps physicians to save time and avoid errors. The French company is looking for clinical partnerships to validate its solution and continue to bring high-value-added functionalities to clinicians.

Si desea más información sobre la oportunidad tecnológica, envíe un e-mail indicando la referencia a CONTACTO